Between the Sheets | July 2022
QUESTION FROM PROSTATE CANCER SURVIVOR: I am a 52-year old gay man whose 10-year relationship just ended. That was a... Read More
QUESTION FROM PROSTATE CANCER SURVIVOR: I am a 52-year old gay man whose 10-year relationship just ended. That was a... Read More
By Zachary Klaassen, MD, MSc If you’ve been diagnosed with metastatic hormone-sensitive prostate cancer (mHSPC), you have many treatment options.... Read More
HAMPTON ROADS, Va. – ZERO is the leading national nonprofit with the mission to end prostate cancer through advancing research,... Read More
toTODAY’s Al Roker walked the runway at the Blue Jacket Fashion Show on Thursday. Roker strutted the catwalk for a... Read More
Vogue’s first and only black creative director, André Leon Talley, will be honored at New York Fashion Week on Thursday,... Read More
In December, researchers reported findings from a study showing that the drug abiraterone halves the risk of prostate cancer death among... Read More
Washington, D.C. (December 20, 2021) – Today marks the formation of The Cancer Early Detection Alliance (CEDA), a unique collaboration... Read More
Prostate cancer is the most common cancer for men and, for men in the United States, it’s the second leading... Read More
Men who inherit mutations in a gene called TP53 have a high risk of developing aggressive prostate cancer, a multicenter... Read More
My name is Sherry Denton, and I am a nurse practitioner, the director of a prostate cancer clinic in Little... Read More